Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for lung cancer

C T Lee1, H L Chen, D P Carbone

  • 1Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, USA.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|January 1, 1995
PubMed
Summary

Gene therapy offers a promising approach for lung cancer, utilizing immunity-inducing or directly tumoricidal genes. This strategy aims to improve outcomes where traditional chemotherapy falls short.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA.

ESMO open·2025
Same author

Vaping, Smoking and Lung Cancer Risk.

Journal of oncology research and therapy·2024
Same author

Chinese family care partners of older adults in Canada have grit: A qualitative study.

Journal of advanced nursing·2023
Same author

Genomic characterization of thymic epithelial tumors in a real-world dataset.

ESMO open·2023
Same author

Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].

ESMO open·2021
Same author

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.

ESMO open·2021

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Lung cancer remains a primary cause of cancer mortality globally.
  • Standard chemotherapies provide limited improvements in patient outcomes.
  • Gene therapy presents an attractive experimental strategy for treating lung cancer.

Purpose of the Study:

  • To explore the potential of gene therapy as an alternative treatment for lung cancer.
  • To review the different types of genes and delivery methods used in experimental lung cancer gene therapy.

Main Methods:

  • Categorization of gene therapy approaches into immunity-inducing and directly tumoricidal strategies.
  • Identification of specific genes used in each category, including MHC molecules, costimulatory molecules, cytokines (IL-2, IL-4, IL-6, GM-CSF), tumor suppressor genes, and enzyme-prodrug systems (herpes thymidine kinase).
  • Discussion of various gene delivery vehicles, such as retroviruses, adenovirus vectors, and direct DNA delivery.

Main Results:

  • Immunity-inducing genes aim to stimulate systemic immune responses against tumor antigens.
  • Directly tumoricidal approaches involve reintroducing tumor suppressor genes or utilizing enzyme-prodrug systems for targeted cancer cell killing.
  • Different gene delivery vectors offer distinct advantages for therapeutic application.

Conclusions:

  • Gene therapy holds significant potential for advancing lung cancer treatment beyond conventional chemotherapy.
  • The strategic use of specific genes and effective delivery systems is crucial for successful therapeutic outcomes.
  • Further research and clinical application of gene therapy could lead to improved survival rates for lung cancer patients.

Related Experiment Videos